Studying metabolism as targetable weakness of prostate cancer
Professor Teemu Murtola leads a research team focusing on defining the roles of prrostate cancer cells’ metabolism in disease progression and as targetable weakness to improve oncological outcomes. Their work focuses especially on lipid metabolism, which is targeted pharmacologically with statins and clinically with exercise and dietary interventions.
The research group utilises transdisciplinary methodology, where research hypotheses are first tested in laboratory experiments, after which their potential clinical relevance are evaluated in epidemiological studies, and the most promising findings will be finally proven in clinical trials.
Contact
Teemu Murtola, Principal Investigator
teemu.murtola@tuni.fi